Group 4/14 Element Organic Compounds TRIZ Cases

Branched-alkyl organotin EUV resists improve fine-pattern resolution and cut line width roughness while limiting metal contamination.

Terminal CF3 fluorinated silane structures improve water- and oil-repellency while retaining surface bonding across different substrates.

A Formula 1 heterocyclic dopant boosts green OLED luminance and response speed while keeping driving voltage low in standard emission layers.

An aromatic fluorine-containing silane boosts substrate water- and oil-repellency through a surface-treatable Si functional group.

Dual-modified nanoparticles curb agglomeration in photo-curing display coatings, cutting haze while improving abrasion and liquid repellency.

Novel lipid nanoparticle compositions protect unstable RNA and improve cell entry, increasing delivery safety, efficacy, and specificity.

RF pulse sequences and higher magnetic fields boost parahydrogen polarization transfer to produce MRI-ready metabolites at useful volume and concentration.

A phenol compound covalently binds KRAS G12C mutant cysteine to inhibit signaling and promote apoptosis in targeted cancer therapy.

Specialized disilazane precursors enable self-limiting ALD above 500°C, producing conformal silicon oxide films with lower impurities.

Specific OLED organic compounds optimize energy levels and charge mobility to boost luminous efficiency and extend device lifespan.

A three-step route achieves stereoselective β-anomer production of 4′-thio-5-aza-2′-deoxycytidine without purification, lowering cost.

C4-substituted tryptamine salts improve receptor targeting and extend drug action to reduce side effects and frequent dosing.

Balanced bipolar compounds in the OLED emitting layer improve hole mobility, lower operating voltage, and extend blue-emission lifespan.

Reductive amination of aldehyde-functional organosilicon compounds improves purity and avoids SiH, allylamine, and ammonium chloride residues.

Twisted polycyclic emitters in the light-emitting layer raise blue OLED efficiency above 20% EQE while improving lifespan stability.

Ligand modification adds long alkyl chains so olefin polymerization catalysts dissolve in isohexane without losing thermal stability or activity.

Metal-ligand catalyst complexes tune olefin polymerization to produce high-molecular-weight polymers with narrow molecular weight distribution.

A boron dopant in a host matrix improves exciton energy transfer, raising OLED luminous efficiency while enabling lower-voltage driving.

Meta-linked fluorene and spirofluorene structures limit conjugation to raise T1 energy, improving phosphorescent dopant transfer and OLED life.

Cyclization converts aromatic acrylic acid derivatives into cyclic 2-amino-1-ones with lower polarity, better brain uptake, and slower excretion.

Visible-light photoredox catalysis uses D2O to selectively deuterate aromatic and aliphatic aldehydes at C-1 without ring labeling.

Organoboron emitters help OLEDs produce saturated red, green, and blue light directly, reducing filter losses and stack complexity.

An aza-fused organic p-type dopant improves hole injection while lowering volatility, contamination, drive voltage, and OLED energy use.

Methacrylate-functionalized phthalocyanines improve aqueous formulability and PSMA targeting for more stable, precise cancer photodynamic therapy.

A cross-linked HNA nucleoside balances binding affinity with nuclease resistance while reducing hepatotoxicity for therapeutic nucleic acids.

A spirofluorene host with indolocarbazole and dibenzofuran limits conjugation spread, raises T1 energy, and reduces aggregation in OLEDs.

A multi-step GB18 synthesis replaces difficult bark extraction, enabling more reliable access to opioid receptor antagonist and agonist compounds.

A nitrogen-containing compound in OLED functional layers improves emission efficiency, lowers driving voltage, and extends element lifetime.

Nitrogen-containing heterocyclic MYT1 inhibitors expand treatment options for cancers with DDR pathway abnormalities beyond PARP-targeted therapy.

Aspartate silane compounds improve optical fiber coating adhesion while avoiding uncontrolled isocyanate reactions and tin catalysts.